A CASE OF SYSTEMIC SCLEROSIS SINE SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE WITHOUT A POSITIVE ANA?

被引：0
|
作者：
Djondo, Daniel
机构：
来源：
CHEST | 2018年 / 154卷 / 04期
关键词：
D O I：
10.1016/j.chest.2018.08.861
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：957A / 957A
页数：1
相关论文
共 50 条
  • [31] Defining genetic risk factors for scleroderma-associated interstitial lung disease IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
    Stock, Carmel J. W.
    De Lauretis, Angelo
    Visca, Dina
    Daccord, Cecile
    Kokosi, Maria
    Kouranos, Vasilis
    Margaritopoulos, George
    George, Peter M.
    Molyneaux, Philip L.
    Nihtyanova, Svetlana
    Chua, Felix
    Maher, Toby M.
    Ong, Voon
    Abraham, David J.
    Denton, Christopher P.
    Wells, Athol U.
    Wain, Louise V.
    Renzoni, Elisabetta A.
    CLINICAL RHEUMATOLOGY, 2020, 39 (04) : 1173 - 1179
  • [32] Systemic sclerosis sine scleroderma associated with antiphospholipid syndrome
    Pollyanna d’Ávila Leite
    Jozélio Freire de Carvalho
    Rheumatology International, 2012, 32 : 3265 - 3268
  • [33] Systemic sclerosis sine scleroderma associated with antiphospholipid syndrome
    Leite, Pollyanna d'Avila
    de Carvalho, Jozelio Freire
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (10) : 3265 - 3268
  • [34] Defining genetic risk factors for scleroderma-associated interstitial lung diseaseIRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
    Carmel J. W. Stock
    Angelo De Lauretis
    Dina Visca
    Cecile Daccord
    Maria Kokosi
    Vasilis Kouranos
    George Margaritopoulos
    Peter M. George
    Philip L. Molyneaux
    Svetlana Nihtyanova
    Felix Chua
    Toby M. Maher
    Voon Ong
    David J. Abraham
    Christopher P. Denton
    Athol U. Wells
    Louise V. Wain
    Elisabetta A. Renzoni
    Clinical Rheumatology, 2020, 39 : 1173 - 1179
  • [35] Systemic sclerosis sine scleroderma presenting as nonspecific interstitial pneumonia (NSIP)
    Alturkmani, R.
    Kadaria, D.
    Ali, M.
    Koirala, K.
    Freire, A. X.
    Muthiah, M. P.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (01) : 412 - 413
  • [36] THE STABILIZATION OF LUNG FUNCTION IN PATIENTS WITH SCLERODERMA-ASSOCIATED INTERSTITIAL LUNG DISEASE DURING MYCOPHENOLATE MOFETIL THERAPY
    Koneva, O.
    Ananjeva, L.
    Korzeneva, L.
    Alekperov, R.
    Desinova, O.
    Starovoytova, M.
    Nevskaja, T.
    Ovsjannikova, O.
    RHEUMATOLOGY, 2012, 51 : 84 - 84
  • [37] Cyclophosphamide refractory scleroderma-associated interstitial lung disease: dramatic clinical and radiological response to rituximab
    Haroon, M.
    Ryan, J. G.
    Henry, M.
    Harney, S.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2011, 180 : S173 - S173
  • [38] Epidemiology of systemic sclerosis and systemic sclerosis-associated interstitial lung disease
    Bergamasco, Aurore
    Hartmann, Nadine
    Wallace, Laura
    Verpillat, Patrice
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 257 - 273
  • [39] Systemic sclerosis-associated interstitial lung disease
    Scallan, Ciaran J.
    Collins, Bridget F.
    Raghu, Ganesh
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (05) : 487 - 495
  • [40] Pathogenesis of systemic sclerosis associated interstitial lung disease
    Nihtyanova, Svetlana, I
    Denton, Christopher P.
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2020, 5 (2_SUPPL) : 6 - 16
12345